Emergen Research has recently added a new report titled Global Minimally Invasive Biopsy Technologies Market Forecast to 2027 that offers a comprehensive idea about the vital elements of the Minimally Invasive Biopsy Technologies market. The report estimates the market is expected to show significant growth over the projected timeline owing to technological advancements and developments. The report thoroughly examines the historical data (2018-2019) and current market scenario to offer accurate estimations for the growth of the industry in the forecast timeline 2020-2027. The report also offers insightful data about market drivers and restraints, threats, opportunities, and current and emerging trends of the market.
Considerable numbers of the overall open excisional biopsy have been replaced by the minimally invasive biopsy technology in patients having the imaging-detected suspicious or the indeterminate breast lesions. With minimally invasive surgeries in the biopsy, higher precisions can be accumulated, which in turn helps in reducing the psychological burden that affects the patients and also helps reduce the overall cost by a significant margin.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/75
Further key findings from the report suggest
- The therapeutic application is further segmented into Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, and Non-oncology Application. Minimally invasive breast biopsy (MIBB) has been highly recommended for the pre breast cancer diagnosis and checkup globally. The MIBB is expected to grow higher during the projected period as the number of breast cancer increases.
- The Asia Pacific region, due to its immense rise in the breast & lung cancers & rising usage of the MIB technologies, is expected to accelerate with the fastest growth rate of 20.1% during the projected period 2020 to 2027.
- Key players in the market include Chronix Biomedical, Biocept, Inc., F. Hoffmann-La Roche Ltd, Mauna Kea Technologies, Veracyte, Inc., Thermo Fisher Scientific, NeoGenomics Laboratories, Inc., Abcodia Ltd., Adaptive Biotechnologies, and Owlstone Medical Ltd., among others.
Minimally Invasive Biopsy Technologies Market Segmentation:
For the purpose of this report, Emergen Research has segmented into the global Minimally Invasive Biopsy Technologies Market on the basis of Technology, Therapeutic Application, End-Use Verticals, and region:
- Technology Outlook (Revenue: USD Billion; 2017-2027)
- Liquid Biopsy
- Optical Biopsy
- Brush Biopsy
- Pigmented Lesion Assays
- Breath Biopsy
- Brush Biopsy
- Others
- Therapeutic Application Outlook (Revenue: USD Billion; 2017-2027)
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Blood Cancer
- Non-oncology Applications
- End-Use Verticals Outlook (Revenue: USD Billion; 2017-2027)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Others
The regional bifurcation of the market analyzes key market segments such as North America, Latin America, Europe, AsiaPacific, and Middle East & Africa.In conclusion, the research report on the Minimally Invasive Biopsy Technologies market assesses growth prospects, opportunities, challenges, risks, threats, and trends to offer a comprehensive idea of the regional and global Minimally Invasive Biopsy Technologies market.
Request a customized copy of the Minimally Invasive Biopsy Technologies market report @ https://www.emergenresearch.com/request-for-customization/75
Key Benefits of the Global Minimally Invasive Biopsy Technologies Market Report:
- Comprehensive analysis of the changing competitive landscape
- Assists in decision making processes for the businesses along with detailed strategic planning methodologies
- The report offers an 8-year forecast estimation and assessment of the Global Minimally Invasive Biopsy Technologies Market
- Helps in understanding the key product segments and their estimated growth rate
- In-depth analysis of market drivers, restraints, trends, and opportunities
- Comprehensive regional analysis of the Global Minimally Invasive Biopsy Technologies Market
- Extensive profiling of the key stakeholders of the business sphere
- Detailed analysis of the factors influencing the growth of the Global Minimally Invasive Biopsy Technologies Market
Table Of Content:
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Minimally Invasive Biopsy Technologies Market Segmentation & Impact Analysis
4.1. Minimally Invasive Biopsy Technologies Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing proliferation of the minimally invasive surgical procedure
4.2.2.2. Extensive rise in the cancers & biopsy testing
4.2.2.3. Minimum hospitalization for biopsy testing
4.2.3. Market restraints analysis
4.2.3.1. Unavailability of the skilled professional
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
READ MORE…!
Gain access to the full report by clicking here on the link @ https://www.emergenresearch.com/industry-report/minimally-invasive-biopsy-technologies-market
Thank you for reading our report. Customization of this report is available as per client requirements. Please connect with us to know more about the report, and our team will ensure you get the report tailored according to your needs.
Have a Look at Related Reports:
Solid Waste Management Market@ https://www.google.hn/url?q=https://www.emergenresearch.com/industry-report/solid-waste-management-market
Hematologic Malignancies Testing Market@ https://www.google.hu/url?q=https://www.emergenresearch.com/industry-report/hematologic-malignancies-testing-market
Industrial Microbiology Market@ https://www.google.is/url?q=https://www.emergenresearch.com/industry-report/industrial-microbiology-market
Blockchain in Genomics Market@ https://www.google.co.id/url?q=https://www.emergenresearch.com/industry-report/blockchain-in-genomics-market
Prenatal Testing Market@ https://www.google.iq/url?q=https://www.emergenresearch.com/industry-report/prenatal-testing-market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
